Generics v Lundbeck

19.05.08

Within its judgment in Generics v Lundbeck, the Court of Appeal has provided important guidance on the judgment of the House of Lords in Biogen v Medeva regarding the enabling disclosure the specification must provide to support the claims in the patent.

For more on this, read Wragge & Co's expert analysis.

Key Contact

Gordon Harris, partner, +44 (0)121 629 1499 / +44 (0)20 7664 0326, gordon_harris@wragge.com

This alert may contain information of general interest about current legal issues, but does not give legal advice.